Skip to main content

Table 2 Samples set characterization

From: Molecular and epigenetic features of melanomas and tumor immune microenvironment linked to durable remission to ipilimumab-based immunotherapy in metastatic patients

Variable

Number of samples (n = 20)

Biopsy time point

 Before treatment

12 (60 %)

 After treatment

8 (40 %)

Tissue type

Total

Before therapy

After therapy

Lymph node

8 (40 %)

7

1

Skin

1 (5 %)

1

 

Nodule subcutaneous

5 (25 %)

1

4

Liver

1 (5 %)

 

1

Small intestine

2 (10 %)

1

1

Adrenal gland

1 (5 %)

1

 

Brain

1 (5 %)

 

1

Lung

1 (5 %)

1